Speakers Abraham Scaria Chief Scientific Officer Beacon Therapeutics Adam Silverman Vice President - Protein Sciences Spotlight Therapeutics Aniz Girach Chief Medical Officer Splice Bio Arun Upadhyay Chief Scientific Officer, Head of R&D Ocugen Christopher Chavez Vice President, Research & Development Visgenx Inc. Claire Gelfman Chief Scientific Officer Foundation Fighting Blindness Emily Warner Principal Scientist Ikarovec Eric Kelsic Founder & Chief Executive Officer Dyno Therapeutics Hanen Khabou Senior Scientist SparingVision Hemant Khanna Vice President, Preclinical Ocular Research IVERIC Bio Jean Chang Vice President, Clinical Operations Nanoscope Therapeutics Inc. Kali Stasi Senior Vice President, Clinical Development Adverum Kenji Fujita Chief Medical Officer Atsena Therapeutics Maryam Moktarzadeh Senior Director, Regulatory Strategy REGENXBIO Melissa Calton Vice President, Early-Stage Product Development 4D Molecular Therapeutics Molly Johnson Director, Data Science Avista Therapeutics Moshe Weinstein Chief Executive Officer, Ophthalmics Everads-Therapy Paul Wille Director, Product Development Process Development Abeona Therapeutics Peter Francis Chief Scientific & Medical Officer Ray Therapeutics Rob Collin Chief Scientific Officer Astherna BV Sarah DiSalvatore Vice President, Clinical Operations Ascidian Therapeutics Stephen Poor Executive Director & Head of Global Program Clinical Ophthalmology Novartis AG Szilard Kiss Chief Medical Officer & Co-Founder BlueGen Therapeutics Viral Kansara Vice President, Preclinical Development Clearside Biomedical Zhongdong Shi Executive Director & Head of Vector Research & Development Research and Development Frontera Therapeutics EVENT GUIDE